CAPE TOWN, South Africa--(BUSINESS WIRE)--The markets for generic infectious disease pharmaceuticals in sub-Saharan Africa hold considerable potential. Despite high levels of poverty and market price sensitivity, the region has a large and growing population that is increasingly able to pay for better health services and pharmaceutical products.
